| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 11/18/2022 | Gamida Cell Ltd. | GMDA | Grant | Ordinary Shares | 2k | $0.00 | $0 | | 11/18/2022 |
| 11/18/2022 | Gamida Cell Ltd. | GMDA | Grant | Share Option (Right to Buy) | 9.5k | $1.79 | $17k | | 11/18/2022 |
| 06/14/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Common Stock | 23.1k | $0.00 | $0 | | 06/14/2022 |
| 06/14/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | Sale | Common Stock | 40 | $1.01 | $40.4 | | 06/14/2022 |
| 06/14/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 34.7k | $1.01 | $35k | | 06/14/2022 |
| 08/03/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 7.5k | $4.44 | $33.3k | | 08/03/2021 |
| 08/03/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Common Stock | 5k | $0.00 | $0 | | 08/03/2021 |
| 06/10/2020 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $5.21 | $78.2k | | 06/10/2020 |
| 10/01/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 1.3k | $7.36 | $9.9k | | 10/01/2019 |
| 07/01/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 666 | $14.11 | $9.4k | | 07/01/2019 |
| 06/11/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $13.50 | $202.5k | | 06/11/2019 |
| 04/01/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 1.7k | $5.40 | $9.3k | | 04/01/2019 |
| 01/02/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 2.4k | $3.72 | $9.1k | | 01/02/2019 |
| 10/01/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 1.2k | $7.86 | $9.1k | | 10/01/2018 |
| 07/02/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 952 | $9.70 | $9.2k | | 07/02/2018 |
| 06/06/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $11.30 | $169.5k | | 06/06/2018 |
| 04/02/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 1.2k | $7.98 | $9.3k | | 04/02/2018 |
| 01/02/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 716 | $13.00 | $9.3k | | 01/02/2018 |
| 10/02/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 971 | $8.69 | $8.4k | | 10/02/2017 |
| 07/03/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 500 | $16.90 | $8.4k | | 07/03/2017 |
| 06/07/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $18.77 | $281.6k | | 06/07/2017 |
| 04/03/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 416 | $20.32 | $8.5k | | 04/03/2017 |
| 05/25/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option (right to buy) | 15k | $7.90 | $118.5k | | 05/25/2016 |
| 08/04/2015 | Zynerba Pharmaceuticals, Inc. | ZYNE | Grant | Stock Option | 35k | $14.00 | $490k | | 08/04/2015 |
| 03/13/2014 | CHIMERIX INC | CMRX | Sale | Common Stock | 19k | $25.00 | $474.5k | | 03/13/2014 |
| 03/13/2014 | CHIMERIX INC | CMRX | Exercise | Stock Option (Right to Buy) | 15k | $1.57 | $23.6k | | 03/13/2014 |
| 02/24/2014 | CHIMERIX INC | CMRX | Sale | Common Stock | 11.1k | $20.00 | $221.4k | | 02/24/2014 |
| 02/24/2014 | CHIMERIX INC | CMRX | Exercise | Stock Option (Right to Buy) | 9.1k | $1.57 | $14.2k | | 02/24/2014 |
| 01/30/2014 | CHIMERIX INC | CMRX | Sale | Common Stock | 928 | $20.00 | $18.6k | | 01/30/2014 |
| 01/30/2014 | CHIMERIX INC | CMRX | Exercise | Stock Option (Right to Buy) | 928 | $1.57 | $1.5k | | 01/30/2014 |
| 01/28/2014 | CHIMERIX INC | CMRX | Grant | Stock Option (Right to Buy) | 190.8k | $18.75 | $3.6M | | 01/28/2014 |
| 11/15/2013 | CHIMERIX INC | CMRX | Sale | Common Stock | 2.5k | $15.62 | $39k | | 11/15/2013 |
| 11/15/2013 | CHIMERIX INC | CMRX | Exercise | Restricted Stock Unit | 8.5k | $0.00 | $0 | | 11/15/2013 |